Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · United Bankshares (UBSI)

United Bankshares adds Dr. Sara DuMond to board, effective Oct. 21, 2024

Neutral Impact 2 of 5 leadership Written later

United Bankshares increased its board to 15 members and appointed Dr. Sara DuMond as an independent director to fill the new seat, effective October 21, 2024. DuMond is a practicing pediatrician and founder and CEO of Pediatric Housecalls, PLLC, and the filing reports no financial results or deal terms.

Key points

  • Board size increased to 15 members on August 26, 2024, creating the seat DuMond fills
  • Appointment effective October 21, 2024; DuMond has not yet been named to any board committee
  • DuMond will receive compensation under the standard arrangements for non-employee directors described in the April 2, 2024 proxy statement
  • DuMond is founder and CEO of Pediatric Housecalls, PLLC, and a board-certified pediatrician

The filing

CompanyUnited Bankshares (UBSI)
Form8-K, current report
Filed with the SECAug 26, 2024, 3:41 PM ET
Accession number0001193125-24-207038

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 12:59 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 26, 2024.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.